Therefore, it’s possible that ISL reduced VEGF production in breast cancer cells by increasing HIF-1 proteasome degradation and interacted directly with VEGFR2 to limit its kinase activity [98]. The gene discussed is VEGFA; the disease is breast carcinoma.